Loading…
Monopar Therapeutics Inc. is projected to rise to $82.39 by 2027, a +28% move from its current price of $64.55. MNPR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $62.02 | $64.62 | $67.34 | +0.11% |
| May 30 | $61.04 | $64.69 | $68.57 | +0.22% |
| May 31 | $60.31 | $64.77 | $69.55 | +0.33% |
| Jun 1 | $59.71 | $64.84 | $70.40 | +0.45% |
| Jun 2 | $59.20 | $64.91 | $71.17 | +0.56% |
| Jun 3 | $58.75 | $64.98 | $71.88 | +0.67% |
| Jun 4 | $58.34 | $65.05 | $72.54 | +0.78% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $58.34 | $65.05 | $72.54 | +0.78% |
| Week 2 | $56.21 | $65.56 | $76.48 | +1.57% |
| Week 3 | $54.72 | $66.08 | $79.79 | +2.36% |
| Week 4 | $53.56 | $66.59 | $82.80 | +3.16% |
| Week 5 | $52.61 | $67.11 | $85.62 | +3.97% |
| Week 6 | $51.80 | $67.64 | $88.32 | +4.78% |
| Week 7 | $51.10 | $68.17 | $90.93 | +5.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment of cancer in the United States.
The company develops ALXN1840, MNPR-101, MNPR-101-Zr, and MNPR-101-Lu, and has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease.
The company was founded in 2014 and is headquartered in Wilmette, Illinois.
MNPR (Monopar Therapeutics Inc.) is a healthcare stock trading at $63.12 with a market cap of $422.84M and a rank of 3174.
The 30-day range is $47.44 to $83.99, reflecting near-term variability around the current level.
Forecasts show 2026 with min $50.12, avg $63.12, max $86.47, and a neutral to stable near-term stance, followed by a bullish multi-year path.
A major floor 30.8% below — a decisive break under it would weaken the trend.
The nearest floor, 22.4% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 16.9% above — clearing it would confirm fresh momentum.
Key MNPR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MNPR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $63.58 | Buy | $62.88 | Buy |
| MA 10 | $61.11 | Buy | $61.78 | Buy |
| MA 20 | $59.74 | Buy | $60.26 | Buy |
| MA 50 | $57.28 | Buy | $58.90 | Buy |
| MA 100 | $59.31 | Buy | $59.96 | Buy |
| MA 200 | $64.34 | Buy | $58.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.42 | Neutral |
| Stoch RSI (14) | 62.30 | Neutral |
| CCI (20) | 79.77 | Neutral |
| Williams %R (14) | -9.40 | Info |
| MACD (12,26,9) | 0.36 | Buy |
| ROC (12) | 1.53 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 90.60 | Sell |
| TRIX (15) | 0.37 | Buy |
| Awesome (5,34) | 5.63 | Buy |
| Ultimate (7,14,28) | 59.18 | Neutral |
| Momentum (10) | 3.20 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 64.73 | Sell |
| ADX (14) | 15.68 | Neutral |
| ATR (14) | 2.03 | Info |
The near-term technical picture is BULLISH with RSI(14) at 60.
The stock trades with SMA50 at $57.17 and SMA200 at $64.08, with a defined support at $50.12 and resistance at $65.52.
The 30-day range runs from $47.44 to $83.99, and annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $50.12 | $64.55 | $87.98 | 0% | Neutral | |
| $62.13 | $82.39 | $117.40 | +28% | Bullish | |
| $75.62 | $104.72 | $156.87 | +62% | Bullish | |
| $98.12 | $140.98 | $219.63 | +118% | Bullish | |
| $106.66 | $158.42 | $255.02 | +145% | Bullish | |
| $113.42 | $173.72 | $287.71 | +169% | Bullish | |
| $118.21 | $186.37 | $316.60 | +189% | Bullish | |
| $115.83 | $187.71 | $326.27 | +191% | Bullish | |
| $145.09 | $241.44 | $428.56 | +274% | Bullish | |
| $181.65 | $310.13 | $561.27 | +380% | Bullish | |
| $243.74 | $469.29 | $920.48 | +627% | Bullish | |
| $402.07 | $893.50 | $1,965.96 | +12.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $50.12 | $64.55 | $76.69 | +0.00% |
| June 2026 | $58.58 | $69.56 | $85.12 | +7.76% |
| July 2026 | $59.40 | $71.44 | $89.18 | +2.71% |
| August 2026 | $56.68 | $68.87 | $87.29 | -3.60% |
| September 2026 | $56.36 | $69.05 | $88.60 | +0.26% |
| October 2026 | $57.62 | $71.14 | $92.30 | +3.03% |
| November 2026 | $55.49 | $68.98 | $90.36 | -3.04% |
| December 2026 | $53.19 | $66.55 | $87.98 | -3.52% |
Click any year to see its month-by-month MNPR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MNPR could reach as high as $87.98, with a base case around $64.55 and support toward $50.12 — roughly 0% from $64.55. Price action looks broadly range-bound.
Expect MNPR to range from $62.13 to $117.40 through 2027. The $82.39 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MNPR price prediction for 2028 points to an average of $104.72 (low $75.62, high $156.87) — a potential gain of +62% on today's $64.55. Momentum favours further upside here.
In 2029, MNPR is projected to trade between $98.12 and $219.63, averaging $140.98 — a potential gain of +118% from today's $64.55. That is up +35% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Monopar Therapeutics Inc.'s 2030 outlook centres on $158.42, within a $106.66 to $255.02 range. That is up +12% on the projected 2029 average. That marks a +145% change versus current levels. Momentum favours further upside here.
By 2031, MNPR could reach as high as $287.71, with a base case around $173.72 and support toward $113.42 — roughly +169% from $64.55. Buyers look set to stay in control over this stretch.
Expect MNPR to range from $118.21 to $316.60 through 2032. The $186.37 average target implies a +189% move from current prices. That is up +7% on the projected 2031 average. Momentum favours further upside here.
The MNPR price prediction for 2033 points to an average of $187.71 (low $115.83, high $326.27) — a potential gain of +191% on today's $64.55. Buyers look set to stay in control over this stretch.
In 2034, MNPR is projected to trade between $145.09 and $428.56, averaging $241.44 — a potential gain of +274% from today's $64.55. That is up +29% on the projected 2033 average. Momentum favours further upside here.
Monopar Therapeutics Inc.'s 2035 outlook centres on $310.13, within a $181.65 to $561.27 range. That is up +28% on the projected 2034 average. That marks a +380% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MNPR could reach as high as $920.48, with a base case around $469.29 and support toward $243.74 — roughly +627% from $64.55. Momentum favours further upside here.
Expect MNPR to range from $402.07 to $1,965.96 through 2050. The $893.50 average target implies a +12.8x move from current prices. That is up +90% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MNPR today (≈ 15.491867 MNPR) could be worth
$13,841.93
+$12,841.93 (+1284%) by 2050 · US Dollar
Based on the average projected MNPR price of $893.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MNPRwould be worth at today's price.
$1,000 invested in MNPR on May 27, 2025 (≈ 28.368794 MNPR) would be worth
$1,831.21
+$831.21 (+83.1%) today · 1.83× · US Dollar
Based on a MNPR entry price of $35.25 vs. today's $64.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $64.95 | $993.84 | -0.6% |
| 1 month ago | $54.02 | $1,194.93 | +19.5% |
| 3 months ago | $54.65 | $1,181.04 | +18.1% |
| 6 months ago | $86.18 | $749.01 | -25.1% |
| 1 year ago | $35.25 | $1,831.21 | +83.1% |
| All time (5.0y) ago | $28.8 | $2,241.32 | +124.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MNPR forecast.
Our base-case forecast reaches $130.00 around 2029.
Implied market cap at $130.00: $870.88M
From 2027 through 2050 the forecast shows continued BULLISH sentiment.
Key averages include 2027 $81.41, 2028 $101.82, 2029 $138.98, 2030 $157.10, 2031 $169.08, 2032 $182.43, 2033 $183.05, 2034 $234.64, 2035 $307.59, 2040 $457.22, and 2050 $871.89.
The forecasted ROI progresses from 29 (2027) to 1281.3 (2050), with sustained bullish driver in the later years. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Average price $157.10, a low of $104.09, a high of $256.71, with an ROI of 148.9, sentiment: BULLISH.
Forecasts show bullish sentiment in later years, with 2027 avg $81.41 and ROI 29, 2040 avg $457.22 and ROI 624.4, and 2050 avg $871.89 with ROI 1281.3. These are estimates and not guarantees.
Yes—the forecast for 2028 shows avg $101.82, with a min of $72.69 and a max of $154.44.
Current price is $63.12 and market cap is $422.84M.
RSI(14) is 60; SMA(50) is $57.17; SMA(200) is $64.08; support is $50.12 and resistance is $65.52. The 30-day range is $47.44 to $83.99; annualized volatility is 80%.
Monopar Therapeutics Inc. Community Discussion
0Share your Monopar Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.